D-574-2013 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-574-2013 was initiated by Novartis Consumer Health on Feb 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 99,660 tubes.

Recall details

Product Type
Drugs
Report Date
Jun 12, 2013
Initiation Date
Feb 19, 2013
Termination Date
Nov 26, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
99,660 tubes

Product description

Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..

Distribution pattern

Nationwide and Puerto Rico, and Panama. Military distribution made.

Code information

Lot numbers and exp dates: 10108716 31-Mar-2013, 10111510 30-Apr-2013, 10113801 31-May-2013, 10113839 30-Apr-2013, 10115616 31-Aug-2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-574-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-574-2013. Report a data issue: hello@regdatalab.com.